Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipients

Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipients

Abstract Introduction Intravenous vitamin C was administered following hematopoietic stem cell transplant to mitigate nonrelapse mortality (NRM) in a Phase II clinical trial. Methods Patients with advanced hematologic malignancies received IV vitamin C, 50 mg/kg/day, in three divided doses on days 1...

Full description

Saved in:
Bibliographic Details
Main Authors: Gary L. Simmons, Roy Sabo, Rehan Qayyum, May Aziz, Erika Martin, Robyn J. Bernard, Manjari Sriparna, Cody McIntire, Elizabeth Krieger, Donald F. Brophy, Ramesh Natarajan, Alpha Fowler III, Catherine H. Roberts, Amir Toor
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:eJHaem
Subjects:
allogeneic stem cell transplantation
graft versus host disease
nonrelapse mortality
parenteral ascorbic acid
Online Access:https://doi.org/10.1002/jha2.995
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jha2.995

Similar Items